Total Payments
$265,879
2024 Payments
$51,627
Companies
54
Transactions
1,695
Medicare Patients
6,894
Medicare Billing
$966,006
Payment Breakdown by Category
Other$99,368 (37.4%)
Consulting$96,198 (36.2%)
Food & Beverage$38,396 (14.4%)
Travel$28,398 (10.7%)
Research$2,200 (0.8%)
Education$1,319 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $96,198 | 38 | 36.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $92,018 | 46 | 34.6% |
| Food and Beverage | $38,396 | 1,520 | 14.4% |
| Travel and Lodging | $28,398 | 62 | 10.7% |
| Honoraria | $6,350 | 3 | 2.4% |
| Unspecified | $2,200 | 3 | 0.8% |
| Education | $1,319 | 22 | 0.5% |
| Grant | $1,000 | 1 | 0.4% |
Payments by Type
General
$263,679
1,692 transactions
Research
$2,200
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $74,670 | 201 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $41,873 | 170 | $0 (2024) |
| Lilly USA, LLC | $41,259 | 153 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $38,446 | 96 | $0 (2024) |
| UCB, Inc. | $11,911 | 31 | $0 (2024) |
| GENZYME CORPORATION | $11,637 | 77 | $0 (2024) |
| EPI Health, LLC | $7,367 | 10 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $5,232 | 66 | $0 (2024) |
| PFIZER INC. | $4,322 | 102 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $4,189 | 52 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51,627 | 234 | Novartis Pharmaceuticals Corporation ($15,287) |
| 2023 | $58,681 | 242 | Lilly USA, LLC ($18,059) |
| 2022 | $67,365 | 243 | ABBVIE INC. ($48,432) |
| 2021 | $19,308 | 174 | Novartis Pharmaceuticals Corporation ($12,585) |
| 2020 | $8,521 | 146 | GENZYME CORPORATION ($2,964) |
| 2019 | $51,507 | 281 | Regeneron Healthcare Solutions, Inc. ($24,051) |
| 2018 | $4,261 | 193 | Regeneron Healthcare Solutions, Inc. ($771.20) |
| 2017 | $4,610 | 182 | Medimetriks Pharmaceuticals, Inc. ($735.49) |
All Payment Transactions
1,695 individual payment records from CMS Open Payments — Page 1 of 68
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,875.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Immunology | ||||||
| 12/18/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Inflammation & Immunology | ||||||
| 12/18/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Immunology | ||||||
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Immunology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $34.73 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/11/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $651.97 | General |
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.80 | General |
| Category: Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.87 | General |
| Category: Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.59 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Podiatry | ||||||
| 12/02/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Immunology | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $134.33 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $109.02 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS | Regeneron Pharmaceuticals, Inc. | $1,876 | 2 |
| CLOU064A2301,CLOU064A2302 | Novartis Pharmaceuticals Corporation | $324.09 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,822 | 4,062 | $453,759 | $200,038 |
| 2022 | 22 | 1,786 | 3,775 | $445,191 | $215,418 |
| 2021 | 20 | 1,661 | 4,080 | $456,010 | $246,960 |
| 2020 | 22 | 1,625 | 4,524 | $495,967 | $303,590 |
Total Patients
6,894
Total Services
16,441
Medicare Billing
$966,006
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 26 | 204 | $91,800 | $41,266 | 45.0% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 26 | 209 | $52,250 | $28,347 | 54.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 267 | 346 | $56,915 | $25,991 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 295 | 402 | $46,707 | $23,122 | 49.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 222 | $40,828 | $17,628 | 43.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 277 | 390 | $42,659 | $11,890 | 27.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 146 | 169 | $24,843 | $9,336 | 37.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 228 | 1,438 | $16,278 | $6,473 | 39.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $15,329 | $6,198 | 40.4% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 26 | 197 | $11,032 | $6,105 | 55.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 74 | 74 | $12,597 | $4,832 | 38.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 31 | 36 | $8,089 | $4,093 | 50.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 19 | 21 | $9,097 | $4,050 | 44.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 40 | 73 | $5,256 | $2,799 | 53.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 21 | 22 | $4,033 | $1,561 | 38.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $3,174 | $1,545 | 48.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 17 | $5,592 | $1,519 | 27.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 17 | 17 | $2,975 | $1,508 | 50.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 15 | 21 | $1,369 | $762.02 | 55.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 14 | $1,040 | $548.44 | 52.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 47 | $1,493 | $409.26 | 27.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 28 | 67 | $402.00 | $53.91 | 13.4% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2022 | 29 | 235 | $105,750 | $48,320 | 45.7% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2022 | 30 | 239 | $59,750 | $33,213 | 55.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 279 | 349 | $46,925 | $25,996 | 55.4% |
About Dr. Lindsey Finklea, M.D
Dr. Lindsey Finklea, M.D is a Dermatology healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2009. The National Provider Identifier (NPI) number assigned to this provider is 1528294055.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lindsey Finklea, M.D has received a total of $265,879 in payments from pharmaceutical and medical device companies, with $51,627 received in 2024. These payments were reported across 1,695 transactions from 54 companies. The most common payment nature is "Consulting Fee" ($96,198).
As a Medicare-enrolled provider, Finklea has provided services to 6,894 Medicare beneficiaries, totaling 16,441 services with total Medicare billing of $966,006. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location San Antonio, TX
- Active Since 06/10/2009
- Last Updated 03/25/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1528294055
Products in Payments
- RINVOQ (Biological) $65,524
- DUPIXENT (Biological) $45,794
- OLUMIANT (Drug) $30,739
- Bimzelx (Biological) $11,436
- COSENTYX (Biological) $10,860
- DUPIXENT (Drug) $7,448
- Sitavig (Drug) $7,348
- Sotyktu (Drug) $5,214
- SKYRIZI (Biological) $4,203
- HUMIRA (Biological) $3,727
- SILIQ (Drug) $3,599
- CIBINQO (Drug) $2,946
- TALTZ (Drug) $2,152
- AKLIEF (Drug) $1,909
- Xolair (Biological) $1,903
- ADBRY (Biological) $1,871
- TREMFYA (Drug) $1,665
- EUCRISA (Drug) $1,361
- ENSTILAR (Drug) $1,184
- Tremfya (Drug) $1,126
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in San Antonio
Dr. William Cragun, M.d, M.D
Dermatology — Payments: $1.9M
Dermatology $1.9M
Emily Becker, M.d, M.D
Dermatology — Payments: $937,773
Dermatology $937,773
Dr. Mark Lee, M.d, M.D
Dermatology — Payments: $589,973
Dermatology $589,973
Steven Davis, Md, MD
Dermatology — Payments: $114,713
Dermatology $114,713
Stephen Miller, M.d. P.a, M.D. P.A
Dermatology — Payments: $89,896
Dermatology $89,896
Dr. Mobolaji Opeola, M.d, M.D
Dermatology — Payments: $66,660
Dermatology $66,660